IMATINIB MESYLATE 100 MG TAB

Imatinib Mesylate
$0.8525per EA
Discontinued
Low Outlier

Strength

100 mg/1

NDC

60687019221

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

2/18/2026

Active Ingredients

IMATINIB MESYLATE

Approval Type

Generic (ANDA)

FDA Application

ANDA078340

On Market Since

2/24/2016

Pharmacological Classes

Bcr-Abl Tyrosine Kinase Inhibitors
Cytochrome P450 2D6 Inhibitors
Cytochrome P450 3A4 Inhibitors
Kinase Inhibitor

Price History

1W

0.0%

1M

0.0%

3M

-0.9%

6M

-4.2%

1Y

+3.6%

3Y

+40.0%

5Y

-72.8%

All

-98.9%